Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia".
作者信息
Maglie Roberto, Grandi Vieri, Antiga Emiliano
机构信息
Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy.
出版信息
J Am Acad Dermatol. 2020 Jan;82(1):e15-e16. doi: 10.1016/j.jaad.2019.08.061. Epub 2019 Aug 29.
PMID:31473299
Abstract
摘要
相似文献
1
Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia".回应：“血液系统相关恶性肿瘤所致嗜酸性粒细胞性皮肤病（He Remained）：一种主要与慢性淋巴细胞白血病相关的嗜酸性粒细胞性皮肤病”
J Am Acad Dermatol. 2020 Jan;82(1):e15-e16. doi: 10.1016/j.jaad.2019.08.061. Epub 2019 Aug 29.
2
Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia.血液系统相关恶性肿瘤所致嗜酸性粒细胞性皮肤病（仍存在）：一种主要与慢性淋巴细胞白血病相关的嗜酸性粒细胞性皮肤病。
J Am Acad Dermatol. 2020 Jan;82(1):e13-e14. doi: 10.1016/j.jaad.2019.08.062. Epub 2019 Aug 29.
3
What's in a name? a new nomenclature has been proposed For eosinophilic dermatosis of hematologic malignancy (EDHM): hematologic-related malignancy-induced eosinophilic dermatosis (He Remained).名字有什么含义？针对血液系统恶性肿瘤嗜酸性粒细胞性皮肤病（EDHM）已提出一种新的命名法：血液系统相关恶性肿瘤诱导的嗜酸性粒细胞性皮肤病（He Remained）。 （注：这里“He Remained”可能有误，不太明确准确含义，暂按原文翻译）
Dermatol Online J. 2020 Jun 15;26(6):13030/qt1zd6p6z2.
4
Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?血液系统恶性肿瘤相关嗜酸性粒细胞性皮肤病的火焰状图形：对于血液增殖性疾病患者，能否将该病症与嗜酸性粒细胞性蜂窝织炎区分开来？
Int J Clin Exp Pathol. 2013 Jul 15;6(8):1683-7. Print 2013.
5
Eosinophilic dermatosis of hematologic malignancy.血液系统恶性肿瘤相关嗜酸性粒细胞性皮肤病
J Cutan Pathol. 2012 Jul;39(7):690-5. doi: 10.1111/j.1600-0560.2012.01906.x. Epub 2012 May 22.
6
Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy.度普利尤单抗用于治疗血液系统恶性肿瘤难治性嗜酸性皮肤病。
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e501-e503. doi: 10.1111/jdv.17232. Epub 2021 Mar 28.
7
Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature.模仿水痘带状疱疹感染的血液系统恶性肿瘤嗜酸性粒细胞性皮肤病：1例慢性淋巴细胞白血病女性病例报告及文献复习
Dermatol Pract Concept. 2017 Jul 31;7(3):6-15. doi: 10.5826/dpc.0703a02. eCollection 2017 Jul.
8
Eosinophilic dermatosis of haematological malignancy.血液系统恶性肿瘤相关嗜酸性粒细胞性皮肤病
Clin Exp Dermatol. 2016 Aug;41(6):692-5. doi: 10.1111/ced.12846. Epub 2016 Jul 4.
9
Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed.度普利尤单抗治疗血液系统恶性肿瘤嗜酸性粒细胞性皮肤病（EDHM）的疗效有待证实。
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e213-e215. doi: 10.1111/jdv.17748. Epub 2021 Nov 3.
10
Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy.血液系统恶性肿瘤相关嗜酸性粒细胞性皮肤病：皮肤病变的分子特征与血液系统恶性肿瘤皮肤外表现的相关性
J Cutan Pathol. 2019 Mar;46(3):175-181. doi: 10.1111/cup.13389. Epub 2018 Dec 17.
引用本文的文献
1
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.血液系统恶性肿瘤患者的免疫介导性皮肤病：全面综述。
Am J Clin Dermatol. 2020 Dec;21(6):833-854. doi: 10.1007/s40257-020-00553-9.
Zotero 插件